Acenocoumarol

What is Acenocoumarol?

Acenocoumarol is an oral anticoagulant medication that belongs to the vitamin K antagonist class of drugs. It is used to prevent and treat blood clots by reducing the blood’s ability to clot. This medication is commonly prescribed for patients at risk of thromboembolism or those who have already experienced blood clotting disorders.

Uses

• Deep vein thrombosis prevention and treatment: Used to prevent blood clots from forming in deep veins, particularly in the legs, and to treat existing clots
• Pulmonary embolism: Prevents and treats blood clots that travel to the lungs, which can be life-threatening
• Atrial fibrillation: Reduces stroke risk in patients with this heart rhythm disorder by preventing clot formation in the heart chambers
• Heart valve replacement: Prevents clot formation around mechanical heart valves or in patients with certain valve diseases
• Myocardial infarction prevention: Used in some cases to reduce the risk of repeat heart attacks by preventing coronary artery clots

How it works

Acenocoumarol works by blocking the action of vitamin K in the liver, which is essential for producing several blood clotting factors. By inhibiting the enzyme vitamin K epoxide reductase, the medication reduces the production of clotting factors II, VII, IX, and X. This makes the blood less likely to form clots, but also increases bleeding risk, which is why regular monitoring is essential.

Side effects

Common side effects:

• Easy bruising
• Minor bleeding (nosebleeds, gum bleeding)
• Skin rash
• Hair loss
• Nausea
• Diarrhea
• Loss of appetite
• Abdominal pain

Serious side effects requiring immediate medical attention:

Submit Your Paper

• Severe bleeding (gastrointestinal, intracranial, or other major bleeding)
• Signs of internal bleeding (black stools, blood in urine, severe headache)
• Skin necrosis (rare but serious skin tissue death)
• Purple toe syndrome (painful purple discoloration of toes)
• Severe allergic reactions

Warnings and precautions

• Pregnancy: Acenocoumarol crosses the placenta and can cause birth defects and bleeding in the fetus. It should not be used during pregnancy, especially in the first trimester and near delivery
• Bleeding disorders: Patients with active bleeding, severe liver disease, or bleeding disorders should not use this medication
• Regular monitoring required: Blood clotting tests (INR/PT) must be performed regularly to ensure proper dosing and prevent bleeding complications
• Surgery and dental procedures: The medication may need to be temporarily stopped before surgical or dental procedures to reduce bleeding risk
• Elderly patients: Older adults may be more sensitive to the effects and require lower doses and more frequent monitoring

Interactions

• Antibiotics: Many antibiotics can increase acenocoumarol’s effect by reducing vitamin K-producing bacteria in the gut or interfering with metabolism
• NSAIDs and aspirin: Increase bleeding risk when combined with acenocoumarol due to effects on platelet function and stomach lining
• Vitamin K supplements: Can reduce acenocoumarol’s effectiveness by providing more vitamin K for clotting factor production
• Alcohol: Chronic alcohol use can increase bleeding risk, while acute consumption may affect medication metabolism
• Antifungal medications: Drugs like fluconazole and miconazole can significantly increase acenocoumarol levels
• Herbal supplements: St. John’s wort can reduce effectiveness, while garlic, ginkgo, and ginseng may increase bleeding risk
• Thyroid medications: Can affect acenocoumarol metabolism and may require dose adjustments
• Antiepileptic drugs: Medications like phenytoin and carbamazepine can reduce acenocoumarol effectiveness through enzyme induction

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults is 2-4 mg once daily, usually taken in the evening. The maintenance dose typically ranges from 1-8 mg daily, depending on individual response as measured by INR (International Normalized Ratio) blood tests. The target INR is usually between 2.0-3.0 for most conditions, though some patients with mechanical heart valves may require higher targets of 2.5-3.5. Dosage must be individualized and regularly adjusted based on blood test results. Only a healthcare provider should determine the appropriate dose, as incorrect dosing can lead to serious bleeding complications or treatment failure.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).